Screening and management of glucose metabolism disorders in cystic fibrosis patients. Practices survey in 4 French reference centers;Dépistage et prise en charge des troubles du métabolisme glucidique chez les patients atteints de mucoviscidose. Étude de pratiques au sein du réseau EMERA

Archives de Pediatrie

Volumn 16, Issue 11, 2009, Pages 1435-1442

  Haesebaert, J ^a   Bourdy, S ^a   Perceval, M ^b   Chabloz, C ^b   Nove Josserand, R ^a,c   Reix, P ^a,c   Llerena, C ^d   Wion, N ^e   Touzet, S ^a  

^a HOSPICES CIVILS DE LYON   (France)

^b Réseau EMERA   (France)

^c UNIVERSITÉ LYON 1   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e HÔPITAL MICHALLON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD ANALYSIS; CHILD; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; FRANCE; GLUCOSE BLOOD LEVEL; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; QUESTIONNAIRE; SCHOOL CHILD; SCREENING TEST;

EID: 70350348364     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2009.07.025     Document Type: Article

References (20)

1. Costa M., Potvin S., Berthiaume Y., et al. Diabetes: a major co-morbidity of cystic fibrosis. Diabetes Metab 31 (2005) 221-232
2. HAS, Conférence de consensus. Prise en charge du patient atteint de mucoviscidose, Observance, nutrition, gastro-entérologie et métabolisme. Novembre 2002, 26 p. Disponible sur Internet : URL : http://www.has-sante.fr/portail/upload/docs/application/pdf/mucovisc_nut rition-gastro_long.pdf (site consulté en juillet 2008).
3. Moran A. Diagnosis, screening and management of cystic fibrosis-related diabetes. Curr Diab Rep 2 (2002) 111-115
4. Mackie A.D., Thronton S.D., and Edenborough F.P. Cystic fibrosis-related diabetes. Diabetes Med 20 (2003) 425-436
5. Lanng S., Hansen A., Thorsteinsson B., et al. Glucose tolerance in patients with cystic fibrosis: five year prospective study. Br Med J 311 (1995) 655-659
6. Registre français de la mucoviscidose (RFM) : bilan des données 2005 de l'Observatoire national de la mucoviscidose (ONM), Vaincre la mucoviscidose et Institut national d'études démographiques (INED), Paris, 2007. Disponible sur Internet : URL : http://www.vaincrelamuco.org/ (site consulté en juillet 2008).
7. Bismuth E., Laborde K., Taupin P., et al. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 152 (2008) 540-545
8. Finkelstein S.M. Diabetes mellitus associated with cystic fibrosis. J Pediatr 112 (1988) 373-377
9. Tofe S., Moreno J.C., Maiz L., et al. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur J Endocrinol 152 (2005) 241-247
10. Milla C.E., Warwick W.J., and Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 162 (2000) 891-895
11. Lanng S., Thorsteinsson B., Nerup J., et al. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 151 (1992) 684-687
12. Cawood T.J. Cystic fibrosis related diabetes in adults. Ir Med J 99 (2006) 83-86
13. World Health Organization, International Disease Federation, Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia, report of a WHO/IDF consultation, WHO Library Cataloguing-in-Publication Data, 2006, 46p. Disponible sur Internet : URL : http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20 of%20diabetes_new.pdf (site consulté en juillet 2008).
14. Mohan K., Miller H., Burhan H., et al. Management of cystic fibrosis related diabetes: a survey of UK cystic fibrosis centers. Pediatr Pulmonol 43 (2008) 642-647
15. Mohan V., Alagappan V., Snehalatha C., et al. Insulin and C-peptide responses to glucose load in cystic fibrosis. Diabete Metab 11 (1985) 376-379
16. Management of cystic fibrosis related diabetes mellitus. Report of the UK Cystic Fibrosis Trust Diabetes Working Group. June 2004. Disponible sur Internet : URL : http://www.cftrust.org.uk/aboutcf/publications/consensusdoc/diabetes.pdf (site consulté en juillet 2008).
17. Schwarzenberg S.J., Thomas W., Olsen T.W., et al. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 30 (2007) 1056-1061
18. Battezzati A., Mari A., et al. Contribution of defects in insulin sensitivity and beta-cell function to the changes over time in the glucose tolerance of cystic fibrosis patients. Cystic Fibrosis Conference, Denver, 2006. Pediatr Pulmonol Suppl. 29 (2006) 391-392
19. Saillour-Glenisson F., and Michel P. Individual and collective facilitators of and barriers to the use of clinical practice guidelines by physicians: a literature review. Rev Epidemiol Sante Publique 51 (2003) 65-80
20. Saillour-Glénisson F., Domecq S., Pouchadon M.L., et al. Combined quantitative and qualitative methods to identify local facilitators of and barriers to physician's adherence to clinical practice guidelines. Rev Epidemiol Sante Publique 56 (2008) S207-S219